Company received Complete Response Letter from FDA for avasopasem and intends to request Type A meeting with FDA to discuss potential next steps Cash runway extended into Q2 2024 in connection with. -Today at 07:02 am- MarketScreener
The FDA has issued a Complete Response Letter to Galera Therapeutics regarding the NDA for avasopasem manganese for radiotherapy-induced severe oral mucositis.
Galera Receives Complete Response Letter from U S FDA for Avasopasem Manganese itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.